Minerva Neurosciences logo
Minerva Neurosciences NERV
€ 5.57 4.56%

Geschäftsbericht 2025
hinzugefügt 11.03.2026

report update icon

Minerva Neurosciences Current Ratio 2011-2026 | NERV

Current Ratio Jährlich Minerva Neurosciences

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.419 0.591 0.667 0.733 1.12 8.68 7.11 24.9 18.9 8.66 6.29 5.51 - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
24.9 0.419 6.97

Current Ratio Vierteljährlich Minerva Neurosciences

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
0.45 0.49 0.53 0.59 0.66 0.51 0.58 0.67 0.76 0.84 0.66 0.73 0.81 0.89 0.99 1.12 1.4 1.52 1.68 11.6 11.6 11.6 11.6 1.56 1.56 1.56 1.56 2.85 2.85 2.85 2.85 3.53 3.53 3.53 3.53 4.93 4.93 4.93 4.93 3.03 3.03 3.03 3.03 4.04 4.04 4.04 4.04 3.24 3.24 3.24 - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
11.6 0.45 3.04

Current Ratio anderer Aktien in der Pharmaeinzelhändler

Name Current Ratio Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
1.02 - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
28.7 - 1052.0 % $ 415 M usaUSA
Veracyte Veracyte
VCYT
14.6 $ 30.92 -5.73 % $ 2.43 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
1.6 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
0.995 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12.4 - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
6.48 - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
6.18 - 0.23 % $ 488 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
10.9 - - $ 3.67 B usaUSA
I-Mab I-Mab
IMAB
8.96 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
3.59 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
0.922 - 2.54 % $ 160 B franceFrance
Albireo Pharma Albireo Pharma
ALBO
2.39 - -0.23 % $ 916 M usaUSA
Biophytis SA Biophytis SA
BPTS
1.34 - -13.47 % $ 169 M franceFrance
Aileron Therapeutics Aileron Therapeutics
ALRN
3.34 - 10.36 % $ 9.8 M usaUSA
Aptinyx Aptinyx
APTX
2.35 - -39.0 % $ 4.57 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
2.29 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.02 - -1.52 % $ 24.7 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
10.8 - -6.81 % $ 3.04 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.79 - - $ 26.5 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
3.27 - -52.27 % $ 4.45 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
6.43 - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
2.02 - -11.76 % $ 5.79 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.61 - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
1.46 - - $ 546 M usaUSA
Acasti Pharma Acasti Pharma
ACST
13.4 - 4.01 % $ 150 M canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.04 - - - russiaRussia
Avid Bioservices Avid Bioservices
CDMO
1.22 - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
1.65 - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
0.41 - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
5.93 - -9.65 % $ 45.9 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
1.78 $ 12.67 -9.24 % $ 1.92 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2.14 - 0.49 % $ 251 B cayman-islandsCayman-islands
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
1.19 $ 321.51 -2.03 % $ 42.1 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
2.37 - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
1.83 - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.05 - - $ 3.74 B usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
6.76 $ 1.09 - $ 22.4 M israelIsrael
Enochian Biosciences Enochian Biosciences
ENOB
0.278 - - $ 40.5 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
2.47 - - $ 867 M germanyGermany
Equillium Equillium
EQ
9.69 $ 1.91 -7.28 % $ 109 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.94 $ 19.46 -0.36 % $ 910 M usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
3.17 $ 14.23 -2.97 % $ 5.91 B irlandaIrlanda
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
1.47 - -74.18 % $ 955 K usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
6.6 $ 45.99 -3.28 % $ 4.14 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
5.24 $ 4.33 -2.81 % $ 830 M canadaCanada
Allakos Allakos
ALLK
3.26 - - $ 28.6 M usaUSA
Brickell Biotech Brickell Biotech
BBI
5.28 - -5.38 % $ 6.06 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
2.53 - - $ 384 M britainBritain
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
2.19 - 3.16 % $ 1.9 M usaUSA